Leishmaniasis consists of a complex spectrum of infectious diseases with worldwide distribution of which visceral leishmaniasis or kala-azar caused by Leishmania donovani is the most devastating. In the absence of vaccines, chemotherapy remains the mainstay for the control of leishmaniasis. The drugs of choice are expensive and associated with multiple adverse side effects. Because of these limitations, the development of new antileishmanial compounds is imperative and plants offer prospects in this regard. The present work was conducted to study the antileishmanial potential of oil from Syzygium aromaticum flower buds (clove). The S. aromaticum oil was characterized by gas chromatography and GC-MS and eugenol as well as eugenyl acetate were found to be the most abundant compounds, composing 59.75 % and 29.24 %, respectively of the oil. Our findings have shown that eugenol-rich essential oil from S. aromaticum (EROSA) possesses significant activity against L. donovani, with 50 % inhibitory concentration of 21±0.16 mg ml "1 and 15.24±0.14 mg ml "1 , respectively, against promastigotes and intracellular amastigotes. Alterations in cellular morphology and growth reversibility assay substantiated the leishmanicidal activity of EROSA. The leishmanicidal effect was mediated via apoptosis as confirmed by externalization of phosphatidylserine, DNA nicking by TdT-mediated dUTP nick-end labelling (TUNEL) assay, dyskinetoplastidy, cell cycle arrest at sub-G 0 -G 1 phase, loss of mitochondrial membrane potential and reactive oxygen species generation. EROSA presented no adverse cytotoxic effects against murine macrophages even at 200 mg ml "1 . Our studies authenticate the promising antileishmanial activity of EROSA, which is mediated by programmed cell death, and, accordingly, EROSA may be a source of novel agents for the treatment of leishmaniasis.
INTRODUCTION
Leishmaniasis is a parasitic disease caused by at least 17 protozoan species of the Leishmania genus (Croft & Coombs, 2003) . The forms of the disease are related to the type of parasite and differ in geographical distribution, the host and vector involved, incidence rate and mortality (Ashford et al., 1992) . Visceral leishmaniasis, or kala-azar, caused by Leishmania donovani is the most deadly form of leishmaniasis, affecting millions of people around the world. The toxicity of the present drugs and the emergence of strains that are not responsive to drug therapy have made the discovery of novel therapeutic agents a priority (Iwu et al., 1994) . In this regard, plants are very important sources of diverse types of bioactive organic compounds, including the complex group of essential-oil-related compounds. Essential-oil constituents contribute to beneficial or adverse effects based on their characteristic biological activity. Essential oils are known to possess antibacterial and antifungal properties against human pathogenic micro-organisms (Fyfe et al., 1998) . Antiprotozoal activities of essential oils have also been extensively reviewed (Pérez et al., 2012) . Essential oils obtained from Achillea millefolium and Ocimum basilicum (Santoro et al., 2007) exhibited toxic effects against trypanosomes, which are protozoal species closely related to Leishmania. A plethora of studies indicate promising leishmanicidal effects of essential oils from various plants, including Croton cajucara (Rosa et al., 2003) , Ocimum gratissimum (Ueda-Nakamura Parasite and cell culture. L. donovani parasites, strain MHOM/IN/ 83/AG83, were maintained in vivo in BALB/c mice. Promastigotes were cultured in M199 medium supplemented with 10 % heatinactivated FBS, penicillin G sodium (100 U ml 21 ) and streptomycin sulfate (100 mg ml 21 ) at 22 uC and subcultured every 72 h in the same medium at a mean density of 2610 6 cells ml 21 (Afrin et al., 2001) .
The RAW264.7 cell line was grown at 37 uC in RPMI 1640 medium (pH 7.4) supplemented with 10 % heat-inactivated FBS for 48-72 h in 5 % CO 2 and subcultured in fresh RPMI 1640 medium at a mean density of 2610 5 cells ml 21 .
Plant material. S. aromaticum L. (Myrtaceae) flower buds were purchased from the local market of Khanpur, New Delhi. The plant was authenticated by Dr H. B. Singh, taxonomist, NISCAIR, CSIR, New Delhi (voucher no. 2012 -2013 /2065 .
Extraction of oil from S. aromaticum. The essential oil of the S. aromaticum flower buds was extracted with a modified Clevengertype apparatus (borosilicate), using the steam distillation technique (Gottlieb & Guimaraes, 1960) . After extraction, the essential oil obtained was carefully separated and stored in opaque glass vials with rubber lids, covered with aluminium foil to protect the contents from light, in a refrigerator (220 uC) prior to analysis and biological assays. Stock solutions of 1 mg ml 21 were prepared aseptically in DMSO (cell culture grade) and diluted further in culture medium to achieve a final DMSO concentration of not more than 0.2 %.
GC and GC-MS analysis of oil from S. aromaticum. The chemical composition of the active compounds from S. aromaticum flower bud oil was analysed by GC and GC-MS using a Shimadzu QP2010 with a DB-5 column (30 m, film 0.25 mm, internal diameter 0.25 mm). The temperature of the column was programmed from 45 uC to 270 uC at 5 uC min 21 , the injector and detector temperature for the analysis was 250 uC. Helium was used as the carrier gas at a flow rate of 1.5 ml min 21 . The mass spectrometer was operated in electron impact ionization mode at 70 eV. The chemical constituents of the oil were identified after correlation of their recorded mass spectra with those obtained from the WILEY8.LIB and NIST08.LIB library spectra provided by the software of the GC-MS system (Rosa et al., 2003) , and eugenol was found to be the major constituent.
Antileishmanial activity of eugenol-rich oil of S. aromaticum (EROSA) in a growth kinetics assay. Promastigotes of L. donovani (2610 6 cells ml 21 ) were incubated at 22 uC in the presence of 100 mg ml 21 EROSA in M199 containing 10 % FBS (complete medium). Promastigotes (2610 6 cells ml 21 ) treated with reference drug pentamidine (100 mg ml 21 ) served as positive control; the equivalent number of promastigotes in the medium alone served as negative control, while parasite with 0.2 % DMSO (representing the highest concentration of diluent in the test samples) was taken as solvent control to ensure that the solvent did not have any effect on parasite viability. An aliquot of the treated and untreated parasites was diluted in 16 PBS (pH 7.2) and counted daily for 7 days in a haemocytometer using a phase-contrast microscope under a 640 objective (Afrin et al. 2001) .
Leishmanicidal effect of EROSA in promastigote growth reversibility assay. To confirm the leishmanicidal effect of EROSA, treated and untreated parasites after 7 days of incubation were washed twice with fresh M199 and then resuspended in complete M199 and allowed to grow further at 22 uC. The viable parasites were enumerated microscopically after 4 days (Afrin et al. 2001) .
Determination of 50 % promastigote growth inhibitory concentration (GI 50 ) of EROSA. To determine the GI 50 (the concentration of drugs that inhibits 50 % growth of promastigotes), the parasites at a density of 2610 6 cells ml 21 were incubated without or with EROSA at serial threefold dilutions in triplicates, starting from 100 mg ml 21 , for 4 days at 22 uC. Pentamidine was used as a reference drug. The mean percentage viability was calculated as: (mean cell number of treated promastigotes ml 21 )6100/(mean cell number of untreated promastigotes ml 21 ). Accordingly, GI 50 was determined by graphical extrapolation after plotting the mean percentage viability versus the concentration of the drug.
Analysis of cellular morphology of EROSA-treated promastigotes. Promastigotes (2610 6 cells ml 21 ) were incubated in the presence of EROSA in M199 containing 10 % FBS (complete medium) at a concentration of 100 mg ml 21 . Pentamidine (100 mg ml 21 )-treated promastigotes served as positive control while parasites without drug were taken as negative control. After 4 days of treatment, an aliquot was placed in a haemocytometer and cellular morphology such as elongated, slender, shrunken, oval or round parasites, and loss of flagella were checked under a phase-contrast microscope with a 640 objective. At least 20 microscopic fields were observed for each sample. Data were recorded by using NIS-Elements imaging software.
Antileishmanial activity of EROSA in an ex-vivo macrophageamastigote model. To evaluate the effects of EROSA on intracellular L. donovani amastigote forms, murine macrophages (RAW264.7, 2610 6 cells ml 21 ) were allowed to adhere to round glass coverslips in 24-well tissue culture plates in RPMI 1640 medium supplemented with penicillin G sodium (100 U ml 21 ), streptomycin sulfate (100 mg ml 21 ) and 10 % FBS, and cultured at 37 uC in 5 % CO 2 . After 12 h, adherent macrophages were infected with stationary-phase promastigotes using a cell to parasite ratio of 1 : 10 and incubated at 37 uC for a further 12 h. The non-phagocytosed parasites were removed by gentle washing, and the infected macrophages were incubated for an additional 48 h with EROSA or pentamidine at serial fourfold dilutions in triplicates, starting from 100 mg ml 21 . The coverslips IP: 54.70.40.11
On: Wed, 06 Feb 2019 21:33:43 were fixed in methanol and Giemsa-stained for microscopic evaluation. At least 200 macrophages per coverslip were counted for calculation of mean percentage infection as (number of amastigotes per 200 macrophages in treated group)6100/(number of amastigotes per 200 macrophages in untreated group). The 50 % inhibitory concentration for amastigotes (IC 50 ) was determined by graphical extrapolation .
Visualization of phosphatidylserine (PS) exposure in EROSAtreated promastigotes by annexin V-FITC/propidium iodide (PI) binding. Externalization of PS in the outer membrane of EROSA-treated promastigotes was measured by double staining for annexin V and PI according to Mukherjee et al. (2009) with minor modifications. Briefly, exponential-phase promastigotes (2610 6 cells ml 21 ) were incubated with EROSA at a concentration of 100 mg ml 21 for 72 h. Pentamidine, which has been studied by others for the apoptotic killing of the Leishmania parasites (Nguewa et al., 2005; Singh & Dey 2007) , served as the reference antileishmanial drug. Parasites without any treatment were taken as control. Untreated and treated parasites were centrifuged at 3000 g for 10 min and washed twice in cold PBS, and the pellet was resuspended in annexin V-FLUOS labelling solution (100 ml, containing both annexin V and PI), as per the manufacturer's instructions (Roche). After 15 min of incubation in the dark at 26 uC, 400 ml of incubation buffer was added and data were acquired using a BD LSR II flow cytometer and analysed using Deva software.
Terminal deoxynucleotidyltransferase (TdT)-mediated dUTP nick-end labelling (TUNEL) assay in EROSA-treated promastigotes. DNA fragmentation was detected by catalytically incorporating FITC-dUTP at the 39-hydroxyl end of the fragmented DNA using an in situ cell death detection kit (Roche) as per the manufacturer's instructions. In brief, exponential-phase promastigotes (2610 6 cells ml 21 ) were incubated with EROSA (100 mg ml 21 ), with pentamidine as positive control or with medium alone. After 72 h, the cells were washed, fixed with 4 % paraformaldehyde on ice for 1 h, washed with PBS and incubated with 3 % H 2 O 2 in methanol for 10 min at 25 uC. This was followed by washing with PBS and the cells were then permeabilized with freshly prepared chilled 0.1 % Triton X-100 for 5 min on ice. The cells were washed twice with PBS, after which 50 ml of reaction mixture containing TdT and FLUOS-labelled dUTP was added for 1 h at 37 uC. The cells were washed and finally resuspended in PBS for data acquisition in a BD LSR II flow cytometer and analysed using Deva software. Histogram analysis of FL-1H (x-axis; FITC fluorescence) was recorded to show the shift in fluorescence intensity compared with the control .
Study of dyskinetoplastidy in EROSA-treated parasites by fluorescence microscopy. Exponential-phase promastigotes (2610 6 cells ml 21 ) were treated with EROSA (100 mg ml 21 ) for 72 h at 22 uC, washed twice with PBS, fixed with 80 % chilled ethanol and kept at 4 uC for 24 h. The cells were then washed with PBS and the pellet was resuspended in 500 ml DNase-free RNase (200 mg ml 21 ) for 1 h at 37 uC. The cells were stained with PI (50 mg ml 21 ) and incubated in the dark for 20 min at 4 uC. An aliquot of 20 ml was taken from each sample, placed on a glass microscope slide and observed directly (without fixation) under a high-resolution fluorescence microscope. Images were processed (Singh et al., 2009) using NIS-Elements imaging software. At least 20 microscopic fields were observed for each sample.
Cell cycle analysis in EROSA-treated promastigotes. The potency of EROSA for damaging DNA was detected through flow cytometry by PI staining. Exponential-phase promastigotes (2610 6 cells ml 21 ) were treated with EROSA or pentamidine (100 mg ml 21 ) for 72 h at 22 uC, washed twice with PBS, fixed with 80 % chilled ethanol and kept at 4 uC for 24 h. Cells were then washed with PBS and the pellet was resuspended in 500 ml DNase-free RNase A (200 mg ml 21 ) for 1 h at 37 uC. The cells were stained with PI (50 mg ml 21 ) and incubated in the dark for 20 min at 4 uC. Data acquisition was carried out using a BD FACS Calibur flow cytometer and analysed using CellQuest software .
Determination of mitochondrial membrane potential (DY m ).
Mitochondrial damage was assessed using a cell-permeable dye, JC-1 (Misra et al., 2009) . Briefly, exponential-phase promastigotes after exposure to EROSA or pentamidine (100 mg ml 21 ) for 72 h were centrifuged and loaded with JC-1 (10 mM) in PBS at 37 uC for 10 min. Cells were then analysed by a BD LSR II flow cytometer using DEVA software. The ratio of the red to green fluorescence intensities denoted the relative change in mitochondrial membrane potential (DY m ).
Measurement of intracellular reactive oxygen species (ROS) generation. To monitor the level of ROS generated, the cellpermeant probe, H 2 DCFDA (Misra et al., 2009 ) was used with minor modifications. In brief, promastigotes were treated with EROSA or pentamidine at 22 uC for 72 h. The cells were washed twice with PBS and finally resuspended in 500 ml PBS, loaded with cell-permeant probe H 2 DCFDA (10 mM) and incubated for 30 min at 25 uC. The cells were analysed for intracellular ROS by a BD LSR II flow cytometer and DEVA software.
Cytotoxicity of EROSA to mammalian cells. A murine macrophage cell line (RAW264.7) was cultured in RPMI 1640 medium supplemented with penicillin G sodium (100 U ml 21 ), streptomycin sulfate (100 mg ml 21 ) and 10 % FBS. Macrophages at a density of 1610 6 cells ml 21 were incubated with different concentrations of EROSA (0-200 mg ml 21 ) for 48 h in a CO 2 incubator (5 % CO 2 , 37 uC). Pentamidine served as reference drug and 0.2 % DMSO was used as solvent control. Macrophages without any treatment were taken as control. The cells were observed under a phase-contrast microscope and viability was ascertained by trypan blue dye exclusion (Afrin et al., 2001; Dutta et al., 2008) .
Statistical analysis. In vitro antileishmanial activity was expressed as GI 50 by linear regression analysis. Values are mean±SE of samples in triplicate from at least three independent experiments. Statistical analysis was performed using ANOVA followed by Dunnett's test. *P,0.05, **P,0.01 and ***P,0.001 compared with the control group were considered significant.
RESULTS
GC and GC-MS analysis of S. aromaticum oil GC and GC-MS analysis revealed eugenol (59.75 %) and eugenyl acetate (29.24 %) as the major chemical constituents of S. aromaticum oil ( Fig. 1 in the rate of cell proliferation was observed in the EROSAtreated promastigotes at a concentration of 100 mg ml 21 ; all the cells were morphologically altered and appeared dead after 3 days of incubation ( Fig. 2a ). The established antileishmanial drug pentamidine, used as a positive control, showed a similar trend in time-dependent parasite killing. Solvent control (0.2 % DMSO) showed no adverse effect on promastigote viability (data not shown).
Growth reversibility assay of EROSA-treated promastigotes
To confirm the leishmanicidal effect of EROSA against promastigotes, treated and untreated promastigotes were washed and resuspended in fresh complete medium and their viability was ascertained microscopically after 4 days of incubation. No viable parasites were detected in the case of prior incubation with EROSA or pentamidine (100 mg ml 21 ), corroborating their leishmanicidal effect. In contrast, in untreated control, the residual viable promastigotes expanded and reverted to the late exponential phase (Fig. 2b) .
Evaluation of GI 50
Treatment of promastigotes with EROSA (0-100 mg ml 21 ) demonstrated a dose-dependent inhibition of parasite growth and GI 50 was 21±0.16 mg ml 21 . Pentamidine used as the reference drug also showed a dose-dependent parasite killing, with a GI 50 of 1.6±0.17 mg ml 21 (Fig.  2c) . Parasite viability was unaltered by DMSO (0.2 %, data not shown), proving its inertness.
Alteration in cellular morphology of promastigotes
During the apoptotic mode of cell death, promastigotes alter to an ovoid shape with nuclear condensation, which is accompanied by the formation of fragmented nuclei (Sen et al., 2004) . Visual inspection of cellular morphology of the promastigotes with or without treatment with 100 mg ml 21 EROSA, under a phase-contrast microscope, revealed cell shrinkage and cytoplasmic condensation, resulting in complete circularization of the promastigotes, which had EROSA concn (μg ml -1 ) Fig. 2 . Analysis of anti-promastigote activity of EROSA. Exponential-phase L. donovani promastigotes (2¾10 6 cells ml "1 ) were incubated with 100 mg ml "1 EROSA for 7 days as described in Methods and (a) viable parasites were enumerated microscopically every day, (b) growth reversibility was analysed after 4 days of culturing the treated promastigotes in fresh complete medium, (c) viability (as a percentage of control) was ascertained upon incubation of promastigotes for 4 days with serial threefold dilutions of EROSA (starting from 100 mg ml "1 ) for GI 50 determination and (d) morphology of EROSA-treated promastigotes after 4 days was analysed by light microscopy (¾400). Each point or bar corresponds to the mean±SE of triplicate samples and is representative of one of three independent experiments.
mostly become aflagellated, coupled with substantial reduction in size compared with that of untreated parasites (Fig. 2d ).
Anti-amastigote activity of EROSA
In Leishmania infection, the promastigotes transform into amastigotes within the phagolysosomal vacuoles of macrophages. Accordingly, the antileishmanial activity of EROSA was tested against intracellular amastigotes in L. donovaniinfected RAW264.7 macrophages. Giemsa-stained coverslips were analysed microscopically for the presence of phagocytosed amastigotes within the macrophages. The IC 50 of EROSA and pentamidine for L. donovani amastigotes was found to be 15.25±0.14 and 1.1±0.04 mg ml 21 , respectively (Fig. 3) .
EROSA-treated promastigotes exhibit both annexin V and PI binding
Translocation of phospholipids from the inner side to the outer layer of the plasma membrane is an attribute of cells in the early phase of apoptosis. Annexin V, a Ca 2+dependent phospholipid-binding protein with a high affinity for PS, is routinely used to show externalization of PS. Since annexin V can also label necrotic cells, a propidium iodide (PI) stain was used to differentiate between the apoptotic cells (annexin V +ve and PI 2ve), necrotic cells (annexin V 2ve and PI +ve), late apoptotic cells (annexin V +ve and PI +ve) and live cells (annexin V -ve and PI -ve). Promastigotes treated with EROSA were double-stained with annexin V and PI, and analysed by flow cytometry. As shown in Fig. 4, a EROSA induces in situ DNA nicking in L. donovani promastigotes Fragmentation of nuclear DNA into oligonucleosomal units is one of the biochemical hallmarks of eukaryotic apoptosis. DNA nicking resulting from exposure to EROSA was detected using a TUNEL assay in which the proportion of DNA nicks was quantified by measuring the incorporation of dUTP-FLUOS into the nicked end via TdT. Thus the proportion of DNA nicks was directly proportional to the fluorescence obtained from dUTP-FLUOS. Promastigotes treated with 100 mg ml 21 EROSA for 72 h showed an increase in nuclear DNA fragmentation as evidenced by enhanced dUTP-FLUOS incorporation. The mean fluorescence intensity of untreated promastigotes and promastigotes incubated with EROSA and with pentamidine was found to be 522, 4694 and 3876, respectively (Fig. 5a ).
EROSA-induced cytotoxicity causes dyskinetoplastidy in promastigotes
The kinetoplast is a specialized portion of a mitochondrion comprising a network of circular DNA (kDNA), characteristic of flagellates of the order Kinetoplastida. The kDNA has been shown to be susceptible to elimination (dyskinetoplastidy) by certain DNA-intercalating drugs, for example, acriflavine and berenil. Having observed EROSAinduced genomic DNA damage in L. donovani promastigotes, we next investigated whether EROSA causes any damage to kDNA. Cells were treated with EROSA (100 mg ml 21 ), permeabilized and stained with PI. In untreated promastigotes, the cells appeared with two discrete red spots representing intact kDNA of mitochondria (K) and nucleus (N) respectively. In EROSA-as well as pentamidine-treated promastigotes (72 h), the spots representing the mitochondria were abolished, indicating dyskinetoplastidy (Fig. 5b) .
EROSA-induced apoptosis causes an increase in the sub-G 0 -G 1 population
Flow cytometric analysis after cell permeabilization and labelling with PI is used to quantify the percentage of pseudohypodiploid cells. In a given cell, the amount of PI correlates with the DNA content, and, accordingly, DNA fragmentation in apoptotic cells translates into a sub-G 0 -G 1 peak. Promastigotes treated with EROSA (100 mg ml 21 ) for 72 h caused a hypodiploid peak at sub-G 0 -G 1 , as analysed by flow cytometry (Fig. 6) . The proportion of untreated control parasites in the sub-G 0 -G 1 region of the monoparametric plot of parasites with reduced DNA content was 1.20 %, which increased to 47.58 % and Fig. 4 . Externalization of phosphatidylserine in EROSA-treated promastigotes. Parasites were incubated with EROSA or pentamidine (100 mg ml "1 ) for 72 h, co-stained with PI and annexin V-FITC and analysed by flow cytometry as described in Methods. The percentage of positive cells is indicated in the different quadrants. This is a representative profile of three independent experiments. 18.26 % upon treatment with EROSA and pentamidine, respectively.
Induction of sustained depolarization of mitochondrial membrane
Loss of mitochondrial membrane potential (DY m ), a characteristic feature of metazoan apoptosis, is also evident in protozoans (Sen et al., 2007) . JC-1, a lipophilic fluorescent cation, was used to measure the mitochondrial membrane potential. This dye is known to freely permeate the mitochondrial membrane and form J-aggregates which fluoresce red; accordingly, the viable cells stained with JC-1 exhibit a pronounced red fluorescence. An apoptotic stimulus induces a decrease in the DY m , resulting in failure of JC-1 to enter mitochondria, and JC-1 remains as cytosolic monomers that emit a green fluorescence. Therefore the ratio of J-aggregates to monomers serves as an effective indicator of the mitochondrial energy state of the parasites, allowing apoptotic cells to be easily distinguished from their non-apoptotic counterparts. In untreated promastigotes, the red/green fluorescence ratio was 3.063; treatment with 100 mg ml 21 EROSA or pentamidine for 72 h induced a significant decrease in DY m , resulting in predominance of JC-1 monomers which fluoresce green, thereby translating into a decrease in the mean fluorescence intensity ratio to 0.755 and 0.741, respectively (Fig. 7) .
Pro-oxidant activity of promastigotes exhibited by EROSA
To evaluate the effect of EROSA on the oxidative status of promastigotes, H 2 DCFDA, a lipid-soluble membranepermeable compound, was used based on the evidence that, following cleavage by cellular non-specific esterases, impermeable H 2 DCF is formed which is subsequently oxidized by intracellular ROS to produce a fluorescent compound DCF; therefore, the resultant fluorescence (green) is directly proportional to the quantity of ROS generated. EROSA (100 mg ml 21 ) treatment of promastigotes for 72 h led to a significant increase in ROS levels in comparison with control, as also observed with pentamidine (Fig. 8) .
Cytotoxicity of EROSA to mammalian macrophages
Murine macrophage cell line RAW264.7 was used to check the adverse side effects of EROSA, using pentamidine as reference drug. The cytotoxicity assay revealed that there was no adverse toxicity of EROSA to RAW264.7, even at 200 mg ml 21 (Fig. 9 ). Similar results were obtained with mouse peritoneal macrophages (data not shown).
DISCUSSION
Many traditional medicinal plants have been shown to possess antileishmanial activities validating their use in folk medicine (Rocha et al., 2005) . Plant essential oils and active components can be used as alternatives or additions to current antiparasitic therapies (Pérez et al., 2012) . Leishmanicidal activity of essential oils has been recently documented (Sanchez-Suarez et al., 2013; Rodrigues et al. 2013) . Linalool-rich essential oil from leaves of C. cajucara (Rosa et al., 2003) , eugenol-rich essential oil from O. gratissimum (Ueda-Nakamura et al., 2006) and sesquiterpenes-rich essential oil from E. uniflora (Rodrigues et al., 2013) have been demonstrated to possess cytotoxicity against Leishmania amazonensis parasites. In this study, we have shown, we believe for the first time, that eugenol-rich oil from S. aromaticum (EROSA) induced a profound antileishmanial effect against L. donovani, with IC 50 of G0 6 . Analysis of the cell cycle status of EROSA-treated promastigotes. Exponential-phase promastigotes were incubated with EROSA and pentamidine (100 mg ml "1 ) for 72 h, fixed in chilled methanol, probed with PI and analysed using an LSR II flow cytometer for subsequent analysis using Cell Quest software as described in Methods.
21 mg ml 21 and 15.24 mg ml 21 , respectively, against promastigotes and intracellular amastigotes. The effect was leishmanicidal as also revealed in the promastigote growth reversibility assay and was more pronounced on intracellular amastigotes, suggesting that cellular events might be important for the inhibitory effect of EROSA.
Having established the leishmanicidal effect on L. donovani promastigotes and amastigotes, we sought to delineate the mode of cell death caused by EROSA. In PI-impermeant live cells, PS is predominantly on the annexin Vinaccessible inner leaflet of the cell membrane bilayer. Hence live cells are stained neither by FITC-annexin V (green) nor by PI (red). Apoptosis in metazoan and unicellular cells results in externalization of PS from the inner leaflet to the outer leaflet of the bilayer, rendering apoptotic cells annexinV-positive (green). However these annexinV-positive cells remain PI-negative since they are impermeant to PI. The necrotic (dead) cells become PIpermeable even though they remain negative to annexin V. However, in late apoptotic/secondary apoptotic cells (apoptosis followed by necrosis), cells become positive for both annexin V and PI Saha et al., 2009) . In our studies, EROSA-treated L. donovani promastigotes became positive for both annexin V and PI. Hence, EROSA-induced cell death may be due to loss of membrane integrity, as evidenced by the increase in PI incorporation and annexin V binding, which is indicative of late apoptosis. Apoptosis-like changes that shared several phenotypic features with metazoan apoptosis (Debrabant et al., 2003) have been reported to mediate the leishmanicidal action of camptothecin (Sen et al., 2004) and racemoside A . Further, in situ TUNEL of nicked DNA was observed, thus strongly substantiating apoptosis in L. donovani promastigotes. This has also been evidenced with racemoside A . Apoptotic cells generally feature active endonucleases that preferentially cleave DNA, translating into an increased cell population located proximal to the G 0 -G 1 peak on the left side on a DNA frequency histogram. In promastigotes treated with other antileishmanial drugs such as curcumin, artemisinin and berberine chloride, a substantial proportion of cells have been identified in the sub-G 0 -G 1 region (Das et al., 2008; Sen et al., 2007; Saha et al., 2009; Dutta et al., 2007; Li et al., 2009; Mukherjee et al., 2006) . Our study is in agreement with the previous reports and conclusively shows that EROSA-treated L. donovani promastigotes exhibit a hypodiploid peak at sub-G 0 -G 1 , containing parasites with reduced DNA content, again substantiating DNA fragmentation and induction of apoptosis.
In eukaryotes, mitochondria produce superoxide anions and hydrogen peroxide, which, by changes in electron flow through the electron transport chain, generate reactive intermediates like hydroxyl and other free radicals which subsequently oxidize and damage lipids, proteins and DNA (Jiménez Del Río & Vélez-Pardo, 2004; Azmi et al., 2006) . Damage to mitochondrial DNA causes inhibition of the expression of electron transport proteins, leading to the accumulation of ROS (Van Houten et al., 2006) . Sustained hypopolarization of mitochondrial membrane and generation of ROS have also been established with promastigotes treated with the essential oil of Piper betle (Misra et al., 2009) . We demonstrated that EROSA-induced cell death in L. donovani promastigotes induced loss of DY m and ROS generation, corroborating that the effect was mediated through programmed cell death. The induction of mitochondrial dysfunction in the apoptotic process was apparent in the PI staining results. In the present study, we found that EROSA-induced cell death was accompanied by dyskinetoplastidy, i.e. loss of kDNA network, as has also been affirmed by others (Singh et al., 2009 ). Essential oils have been reported to provoke depolarization of the mitochondrial membranes by decreasing the membrane potential, influencing Ca 2+ cycling (Richter & Schlegel, 1993) and other ionic channels and thereby reducing the pH gradient, and affecting (as in bacteria) the proton pump and the ATP pool. The essential oils change the fluidity of the membranes, which become abnormally permeable, resulting in leakage of free radicals, cytochrome c, calcium ions and proteins, as in the case of oxidative stress and bioenergetic failure. Permeabilization of outer and inner mitochondrial membranes can lead to cell death by apoptosis or necrosis (Yoon et al., 2000) . Pro-oxidant action of eugenol has also been reported to cause cytotoxicity (Fujisawa et al., 2002) . This prompted us to evaluate whether EROSA could induce oxidative stress in L. donovani promastigotes. It is well documented that ROS generation in cells following drug treatment can direct the cells towards apoptosis (Chipuk & Green, 2005) . The increase in ROS after exposure to EROSA followed by death of the parasites suggested that EROSA-mediated generation of ROS by the promastigotes was responsible for their apoptotic death. Earlier studies have established that mitochondria are a possible target of ROS-induced apoptosis in promastigotes which occurs via a decrease in DY m (Sudhandiran & Shaha, 2003) . Further studies were conducted to understand the changes occurring in polarization of mitochondrial membrane after oxidative stress that were responsible for the apoptotic cell death. In our study, the observation of a sharp lowering of DY m evidently indicates that mitochondrial dysfunction occurs, giving evidence of apoptosis in promastigotes upon treatment with EROSA. In line with this, the following Macrophages from the peritoneal cavity of mice were incubated for 72 h at 37 6C in a CO 2 incubator with increasing concentrations of EROSA or pentamidine (0-200 mg ml "1 ) and viability was ascertained. Each bar represents mean±SE of triplicate samples and data are representative of one of three independent experiments.
reaction mechanism for EROSA can be envisaged: the essential oils of S. aromaticum, by penetrating the cytoplasmic membrane, disrupt and permeabilize it and especially damage the mitochondrial membranes.
GC and MS analysis of EROSA revealed significantly higher content of eugenol and eugenyl acetate, which together compose 88.99 % of S. aromaticum oil. Misra et al. (2009) attributed the pro-apoptotic effect of landrace Bangla Mahoba of Piper betle on L. donovani to the high content of eugenol (73.01 %), which also exhibited potent antileishmanial activity, whereas no activity was observed with Piper betle landrace Kapoori Vellaikodi (27.15 % eugenol) . So the findings of Misra et al. also suggest that the antileishmanial activity of EROSA observed by us may be due predominantly to a higher content of eugenol.
Effectiveness of eugenol in stimulating apoptosis is evident in human melanoma cells (Kim et al., 2006) . Moreover, it is known that eugenol at lower concentrations acts as an anti-oxidant and anti-inflammatory agent, whereas at higher concentrations it can work as a pro-oxidant, resulting in enhanced production of tissue-damaging free radicals (Suzuki et al., 1985) . In the present study, apoptosis induced by EROSA was evidenced to be mediated via ROS generation. This finding, along with the fact that eugenol at higher concentrations enhances the generation of ROS and induces apoptosis, validates the antileishmanial efficacy of EROSA, which is likely attributable to the higher eugenol content. The leishmanicidal activity of the eugenol-rich essential oil derived from O. gratissimum further substantiates our observation (Ueda-Nakamura et al., 2006) .
Taken together with the combined use of different apoptotic markers such as PS externalization, in situ DNA nicking, dyskinetoplastidy, cell cycle arrest at sub-G 0 -G 1 phase, reduction of DY m and ROS generation, we have conclusively established that EROSA induced apoptosislike programmed cell death in L. donovani promastigotes with no adverse effect on mammalian cells. Our findings validate eugenol-rich essential oil as a source of a new lead compound for novel antileishmanial drugs.
